ArticleHealth science reports2026
Global Burden of Alcoholic Cardiomyopathy in Adults Aged 60 and Older From 1990 to 2021: A Secondary Analysis of Global Burden of Disease 2021 Data.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alcoholic cardiomyopathy (ACM) poses a significant global health challenge, yet its impact on elderly populations across regions remains underexplored. Methods: Using Global Burden of Disease (GBD) 2021 data sourced from the official visualization platform, we analyzed ACM burden among individuals aged ≥ 60 years across 204 countries (1990-2021). Age-standardized rates (ASR) for prevalence, mortality, and disability-adjusted life years (DALYs) were calculated. Trends were assessed via estimated annual percentage change and Joinpoint regression. Future burden (2022-2050) was projected using Bayesian age-period-cohort models. Inequalities were measured using Slope and Concentration Indices, while frontier analysis identified optimization potential. Results: In 2021, global age-standardized prevalence, mortality, and DALY rates were 19.33, 2.64, and 58.55 per 100,000, respectively, declining since 1990. Eastern Europe exhibited the highest burden (ASDR: 645.87), notably in Hungary, Russia, and Latvia. Males experienced 3-5 times higher rates than females. While Southern Latin America saw substantial declines, the Caribbean observed increases. A positive correlation existed between the Socio-demographic Index (SDI) and ASRs. Decomposition analysis indicated population growth drove prevalence increases, whereas epidemiological improvements reduced mortality. Projections suggest a slight prevalence rise by 2050. Alcohol consumption remained the primary risk factor, especially in high-SDI regions. Conclusion: Although age-standardized ACM burden decreased among the elderly from 1990 to 2021, absolute numbers rose due to population aging and growth. Targeted interventions are needed, particularly in high-burden regions and among males.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.